Search for: "Phase III Investments" Results 21 - 40 of 289
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Apr 2018, 8:51 am by Renae Lloyd
According to reports on Monday, shares of Edge Therapeutics lost almost 92% after the company announced disappointing results from a phase III study, NEWTON 2 on lead pipeline candidate, EG-1962. [read post]
12 Jan 2015, 1:03 pm
We issued the "Phase I" final rule with comment period in 2001; in 2004, we issued the "Phase II" interim final rule with comment period; and, in 2007, we issued the "Phase III" final rule. [read post]
Part I: What Are Third-Party Cookies and Why They Are Important Part II: Privacy Laws and Third-Party Cookies Part III: The Big Tech Phase-Out of the Third-Party Cookie and the Emerging Industry Landscape – Browsers and Mobile Part IV: The Big Tech Phase-Out of the Third-Party Cookie and the Emerging Industry Landscape – First-Party Data — PART IV — Introduction Welcome to the fourth installment in our eight-part series preparing you for the… [read post]
1 Oct 2020, 10:01 am by Renae Lloyd
According to a press release on Dec. 30, 2019, NPXe Limited , a Phase III pharmaceutical and drug delivery device company, announced that it has filed a voluntary petition to reorganize under Chapter 11 of the Bankruptcy Code in the U.S. [read post]
29 Jan 2022, 1:08 am by Badrinath Srinivasan
:Chapter 0: Overview of Lectures: Lecture 0 (link to the Slides)Chapter I: History & Nature of International Investment Law: Lectures 1 to 5 (link to the Slides)Lecture 1: Origins of International Investment Law before 1870 (click on the lecture name)Lecture 2: More About Origins & A Bit about Phase ILecture 3: Inter-War Period & Evolution ThereafterLecture 4: The Era of DichotomyLecture 5: The Eras of Proliferation and ReorientationChapter II:… [read post]
20 Feb 2009, 9:59 pm
The new company will continue to develop the Agennix compound, talactoferrin, which is in Phase III trials for treating non-small cell lung... [read post]
18 Dec 2016, 6:08 am
Qianwen Zhang, Opening Pre-establishment National Treatment in International Investment Agreements: An Emerging “New Normal” in China? [read post]
15 Oct 2015, 9:01 am by Lawrence B. Ebert
Results from a Phase III study of ocrelizumab in people with primary progressive MS are expected later this year; success and approval in progressive MS alone would ensure blockbuster sales. [read post]
7 Oct 2020, 6:29 am by Chelsea Lomprey
Under the Howey test, an investment contract, and thus a security, will exist if the court finds (i) an investment of money, (ii) in a common enterprise, and (iii) with profits to be derived solely from the efforts of others. [read post]
8 Dec 2014, 12:42 pm by Dennis Crouch
 In 2013 Sandoz took two simultaneous actions: (1) it began a major (and expensive) Phase III trial of its version of the treatment product and (2) it filed this declaratory judgment action — asking the federal court for a holding that the Amgen patents are both invalid and would not be infringed by Sandoz’ product. [read post]
8 Jun 2012, 4:46 am by Louis M. Solomon
s discovery of valuable deposits of gold and silver under exploration licenses granted by MINEC for the Respondent; (ii) the Respondent’s failure to protect the Claimant’s investments in accordance with the provisions of its own law and (iii) the Respondent’s unlawful expropriation of the investments of the Claimant (with the Enterprises) in El Salvador. [read post]
5 Dec 2017, 2:09 am by Thilo Danz
In addition, BaFin carried out on-site inspections to ascertain whether the principles regarding distribution were being observed, and to this end evaluated investment advice minutes, among other things. [read post]
27 Nov 2010, 12:29 pm by David Feldman
Some other tidbits/suggestions from this panel: If smaller companies will not be exempt from some of the Dodd-Frank provisions (such as “say on pay”), the SEC should consider phasing them in for smaller companies to give them time to prepare. [read post]
23 Nov 2012, 7:00 am by Stikeman Elliott LLP
Issues identified in the reviews include, among others (i) the inadequate collection and/or documentation of KYC information required to confirm a client's identity, ascertain if the client was an insider of a reporting issuer, or assess the suitability of proposed investments; (ii) unsuitable investments being made; (iii) inadequate or a lack of written policies and procedures regarding KYC, know-your-product and suitability obligations;… [read post]
27 Aug 2020, 2:06 pm by Silver Law Group
On August, 1, 2020, Fennec issued a press release, which stated that it had received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) for a product it is developing called PEDMARK, which has completed its Phase III clinical trial. [read post]
30 Jul 2015, 9:54 am
Fiddy started investing in business ventures in a variety of areas, including the beverages industry, music, clothing, technology, and energy. [read post]
6 Jul 2012, 6:11 pm by vm40@duke.edu
“Kip” Johnson III ’94 will join the Duke Law faculty in July as a senior lecturing fellow and director of the Start-Up Ventures Clinic. [read post]
30 Jul 2011, 6:48 am by Jeff Foust
Marburger III passed away Thursday at the age of 70. [read post]